Loading…
avatar for Mark Kryah

Mark Kryah

Eli Lilly and Company, United States
Senior Advisor/COO, Bio-Medicines Business Unit
Mark Kryah is COO/Senior Advisor in Eli Lilly’s Bio-Medicines Business Unit, leading Phase 3 development in Immunology. He has been leading global development projects for 20+ years, with extensive international and partnership experience. Mark has been involved with DIA for over 15 years, contributing as a presenter/session chair at many Annual Meetings, and served on the Annual Meeting Program Committee from 2013-2018. He is currently Chair of the Project Management Community and is on the DIA Community Leadership Council. Kryah obtained Project Management Professional (PMP) certification from PMI (Project Management Institute) in April 1999 (current). He received a Bachelors in Chemical Engineering from Case Western Reserve University.

My Speakers Sessions

Sunday, June 18
 

10:30am CDT